Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 11/20 | 0.75 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.51 |
| ▸ | SCN5A | Q14524 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | F10 | P00742 | 1/20 | 0.44 |
| ▸ | PTGES | O14684 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.43 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.42 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18172171 | 0.86 | SCN9A (0.78) | SCN9APTGS1SCN5AGAAF10 | |
| SCHEMBL18172119 | 0.86 | SCN9A (1.00) | SCN9APTGS1SCN5AGAAF10 | |
| SCHEMBL18172237 | 0.86 | SCN9A (0.72) | SCN9APTGS1SCN5AGAAF10 | |
| SCHEMBL18172107 | 0.85 | SCN9A (0.80) | SCN9APTGS1SCN5AGAAF10 | |
| SCHEMBL18172216 | 0.83 | SCN9A (0.72) | SCN9APTGS1SCN5AGAAPTGES | |
| SCHEMBL18172174 | 0.83 | SCN9A (0.75) | SCN9APTGS1SCN5AGAAPTGES | |
| SCHEMBL18172037 | 0.83 | SCN9A (0.75) | SCN9APTGS1SCN5AGAAF10 | |
| SCHEMBL18172231 | 0.80 | SCN9A (0.75) | SCN9APTGS1SCN5AGAAF10 | |
| SCHEMBL18172018 | 0.80 | SCN9A (0.72) | SCN9APTGS1SCN5AGAAF10 | |
| SCHEMBL18172235 | 0.80 | SCN9A (0.72) | SCN9APTGS1SCN5AGAAF10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3286178-A1 | AMINO-SUBSTITUTED HETEROCYCLIC DERIVATIVES AS SODIUM CHANNEL INHIBITORS | Almirall S.A. (ES) | 2018-02-28 | — | — | EP | disclosed |
| WO-2016170009-A1 | AMINO-SUBSTITUTED HETEROCYCLIC DERIVATIVES AS SODIUM CHANNEL INHIBITORS | ALMIRALL, S.A. (ES) | 2016-10-27 | — | — | WO | disclosed |